DIZAL

Serial Number 99133024
686

Registration Progress

Application Filed
Apr 11, 2025
Under Examination
Approved for Publication
Oct 7, 2025
Published for Opposition
Oct 7, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Nov 06, 2025 10 days

Trademark Image

DIZAL

Basic Information

Serial Number
99133024
Filing Date
April 11, 2025
Published for Opposition
October 7, 2025
Drawing Code
5

Status Summary

Current Status
Active
Status Code
686
Status Date
Oct 7, 2025
Application
Pending
Classes
005

Rights Holder

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

16
Address
Room 404, 405,416, Building C, Huirong Business Plaza,
26 Hefeng Road, Xinwu District
Wuxi, Jiangsu 214028
CN

Ownership History

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Original Applicant
16
Wuxi, Jiangsu CN

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Owner at Publication
16
Wuxi, Jiangsu CN

Legal Representation

Attorney
Jinggao LI

USPTO Deadlines

Next Deadline
10 days remaining
Notice of Publication
Due Date
November 06, 2025
Extension Available
Until December 06, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

8 events
Date Code Type Description Documents
Oct 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 7, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 9, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 8, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 25, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 11, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 11, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and tumor; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of anti-tumor treatment and cancer; Pharmaceutical products for the prevention and treatment of cancer

Additional Information

Design Mark
The mark consists of the stylized wording, "Dizal".

Classification

International Classes
005